Covalent Laboratories Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
as on 01-01-2025
- Paid Up Capital ₹ 6.00 Cr
as on 01-01-2025
- Company Age 22 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 449.23 Cr
as on 01-01-2025
- Satisfied Charges ₹ 279.50 Cr
as on 01-01-2025
- Revenue 22.76%
(FY 2022)
- Profit -28.06%
(FY 2022)
- Ebitda -25.66%
(FY 2022)
- Net Worth 13.89%
(FY 2022)
- Total Assets 13.96%
(FY 2022)
About Covalent Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 6.00 Cr.
The company currently has active open charges totaling ₹449.23 Cr. The company has closed loans amounting to ₹279.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Narayana Mundla, Maddireddy Vijaykiran, Mundla Vishnu, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24230TG2002PTC039606
- Company No.
039606
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Sep 2002
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Covalent Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madireddy Reddy  | Managing Director | 13-Sep-2002 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Maddireddy Vijaykiran | Whole-Time Director | 13-Sep-2002 | Current |
| Mundla Vishnu | Additional Director | 01-Oct-2024 | Current |
| Narayana Mundla | Director | 15-May-2003 | Current |
| Abhinav Nandigala | Whole-Time Director | 19-Oct-2023 | Current |
| Prasanth Nandigala | Director | 15-May-2003 | Current |
Financial Performance of Covalent Laboratories.
Covalent Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 22.76% increase. The company also saw a substantial fall in profitability, with a 28.06% decrease in profit. The company's net worth Soared by an impressive increase of 13.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Covalent Laboratories?
In 2021, Covalent Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Virchow Petrochemical Private LimitedActive 21 years 7 monthsNarayana Mundla, Mundla Vishnu and 1 more are mutual person
- Andhra Organics LimitedActive 33 years 11 months
Narayana Mundla, Mundla Vishnu and 1 more are mutual person
- Virchow Laboratories LimitedActive 42 years 11 months
Narayana Mundla, Mundla Vishnu and 1 more are mutual person
- Virchow Drugs LimitedActive 20 years 9 months
Narayana Mundla and Prasanth Nandigala are mutual person
Virchow Biotech Private LimitedActive 23 years 9 monthsMundla Vishnu and Prasanth Nandigala are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Citi Bank N.A. Creation Date: 18 Jun 2022 | ₹30.00 Cr | Open |
Others Creation Date: 20 Feb 2020 | ₹50.00 Cr | Open |
Others Creation Date: 04 Feb 2019 | ₹60.00 Cr | Open |
How Many Employees Work at Covalent Laboratories?
Covalent Laboratories has a workforce of 815 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Covalent Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Covalent Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
